These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

456 related items for PubMed ID: 19027619

  • 1. Prevention of cervical cancer.
    Denny L.
    Reprod Health Matters; 2008 Nov; 16(32):18-31. PubMed ID: 19027619
    [Abstract] [Full Text] [Related]

  • 2. Recommendations for cervical cancer prevention in Asia Pacific.
    Garland SM, Cuzick J, Domingo EJ, Goldie SJ, Kim YT, Konno R, Parkin DM, Qiao YL, Sankaranarayanan R, Stern PL, Tay SK, Bosch FX.
    Vaccine; 2008 Aug 19; 26 Suppl 12():M89-98. PubMed ID: 18945418
    [Abstract] [Full Text] [Related]

  • 3. Primary and secondary prevention of cervical cancer--opportunities and challenges.
    Markowitz LE, Unger ER, Saraiya M.
    J Natl Cancer Inst; 2009 Apr 01; 101(7):439-40. PubMed ID: 19318638
    [No Abstract] [Full Text] [Related]

  • 4. Cervical cancer: the sub-Saharan African perspective.
    Anorlu RI.
    Reprod Health Matters; 2008 Nov 01; 16(32):41-9. PubMed ID: 19027621
    [Abstract] [Full Text] [Related]

  • 5. Epidemiology and prevention of cervical cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam.
    Domingo EJ, Noviani R, Noor MR, Ngelangel CA, Limpaphayom KK, Thuan TV, Louie KS, Quinn MA.
    Vaccine; 2008 Aug 19; 26 Suppl 12():M71-9. PubMed ID: 18945416
    [Abstract] [Full Text] [Related]

  • 6. The impact of cytology screening and HPV vaccination on the burden of cervical cancer.
    Tay K, Tay SK.
    Asia Pac J Clin Oncol; 2011 Jun 19; 7(2):154-9. PubMed ID: 21585695
    [Abstract] [Full Text] [Related]

  • 7. Screening and prevention: cervical cancer.
    Weinstein LC, Buchanan EM, Hillson C, Chambers CV.
    Prim Care; 2009 Sep 19; 36(3):559-74. PubMed ID: 19616155
    [Abstract] [Full Text] [Related]

  • 8. Epidemiology and prevention of human papillomavirus and cervical cancer in China and Mongolia.
    Shi JF, Qiao YL, Smith JS, Dondog B, Bao YP, Dai M, Clifford GM, Franceschi S.
    Vaccine; 2008 Aug 19; 26 Suppl 12():M53-9. PubMed ID: 18945414
    [Abstract] [Full Text] [Related]

  • 9. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
    Konno R, Shin HR, Kim YT, Song YS, Sasagawa T, Inoue M, Park JS.
    Vaccine; 2008 Aug 19; 26 Suppl 12():M30-42. PubMed ID: 18945412
    [Abstract] [Full Text] [Related]

  • 10. Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal.
    Sankaranarayanan R, Bhatla N, Gravitt PE, Basu P, Esmy PO, Ashrafunnessa KS, Ariyaratne Y, Shah A, Nene BM.
    Vaccine; 2008 Aug 19; 26 Suppl 12():M43-52. PubMed ID: 18945413
    [Abstract] [Full Text] [Related]

  • 11. The potential cost-effectiveness of adding a human papillomavirus vaccine to the cervical cancer screening programme in South Africa.
    Sinanovic E, Moodley J, Barone MA, Mall S, Cleary S, Harries J.
    Vaccine; 2009 Oct 19; 27(44):6196-202. PubMed ID: 19698807
    [Abstract] [Full Text] [Related]

  • 12. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
    Tay SK, Ngan HY, Chu TY, Cheung AN, Tay EH.
    Vaccine; 2008 Aug 19; 26 Suppl 12():M60-70. PubMed ID: 18945415
    [Abstract] [Full Text] [Related]

  • 13. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
    Garland SM, Brotherton JM, Skinner SR, Pitts M, Saville M, Mola G, Jones RW.
    Vaccine; 2008 Aug 19; 26 Suppl 12():M80-8. PubMed ID: 18945417
    [Abstract] [Full Text] [Related]

  • 14. Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review.
    Louie KS, de Sanjose S, Mayaud P.
    Trop Med Int Health; 2009 Oct 19; 14(10):1287-302. PubMed ID: 19772550
    [Abstract] [Full Text] [Related]

  • 15. Primary and secondary prevention of cervical cancer.
    Grce M.
    Expert Rev Mol Diagn; 2009 Nov 19; 9(8):851-7. PubMed ID: 19895230
    [Abstract] [Full Text] [Related]

  • 16. Vaccination against HPV: indications for women and the impact on the cervical screening programme.
    Heideman DA, Snijders PJ, Berkhof J, Verheijen RH, Helmerhorst TJ, Meijer CJ.
    BJOG; 2008 Jul 19; 115(8):938-46. PubMed ID: 18651878
    [Abstract] [Full Text] [Related]

  • 17. Making the case for cervical cancer prevention: what about equity?
    Tsu VD, Levin CE.
    Reprod Health Matters; 2008 Nov 19; 16(32):104-12. PubMed ID: 19027628
    [Abstract] [Full Text] [Related]

  • 18. Screening the hard to reach: improving morbidity and mortality from cervical cancer in New Zealand.
    Sykes P, Sadler L, Priest P.
    N Z Med J; 2008 Jul 04; 121(1277):5-7. PubMed ID: 18677325
    [No Abstract] [Full Text] [Related]

  • 19. [Screening and vaccination: two synergic tools for the prevention of cervical cancer].
    Zaratti L, Senatore S, Franco E.
    Ig Sanita Pubbl; 2007 Jul 04; 63(4):449-57. PubMed ID: 17912281
    [Abstract] [Full Text] [Related]

  • 20. Exploring the cost-effectiveness of HPV vaccination in Vietnam: insights for evidence-based cervical cancer prevention policy.
    Kim JJ, Kobus KE, Diaz M, O'Shea M, Van Minh H, Goldie SJ.
    Vaccine; 2008 Jul 29; 26(32):4015-24. PubMed ID: 18602731
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.